Dr F. Ghiringhelli
MD, PhD Head of “Cancer and adaptative immune response” INSERM, CGFL (Centre de lutte contre le cancer Georges François Lecrec) Dijon. (FR) Head of the Board
Pr A. Italiano
MD, PhD Head of Early-phase trials units; Head of Precision medicine new program. Gustave Roussy, Cancer Campus Grand Paris (FR) ; Bergnonié Institute, UNICANCER Nouvelle-Aquitaine, Bordeaux. (FR)
Pr A. Eggermont
MD, PhD Head of Clinical & Translational Immunotherapies. UMC (University MC), Utrecht (NL); Chief Scientific Officier. Pediatric oncology center Princessa Maxima, Utrecht. (NL) Past President of EORTC, ECCO, of the European Academy of Cancer Sciences. Past CEO Gustave Roussy. Eur J Cancer Editor in Chief
Pr A. Awada
MD, PhD Head of Oncology medicine Dept. Jules Bordet Institute-HUB, Brussel. (BE) & Board member Oncodistinct clinical and translational research network, ESMO (European Society for Medical Oncology) active member. Expertise in new drugs development
Dr I. Melero
MD, PhD Head of translational immunotherapy research. CIMA (Centro de Investigation Medical Aplicada), Navarra. (SP) Cancer Research Editorial Board Member.
Pr M. Yarchoan
MD Associate Pr. of Medical Oncology at The Sidney Kimmel Comprehensive Cancer Center. Johns Hopkins, Baltimore. (USA)